Who owns the EMPOWERING OLIGONUCLEOTIDE THERAPEUTICS trademark?

The EMPOWERING OLIGONUCLEOTIDE THERAPEUTICS trademark is owned by PepGen Inc..

What class is the EMPOWERING OLIGONUCLEOTIDE THERAPEUTICS trademark registered in?

The EMPOWERING OLIGONUCLEOTIDE THERAPEUTICS trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for EMPOWERING OLIGONUCLEOTIDE THERAPEUTICS?

The USPTO serial number for EMPOWERING OLIGONUCLEOTIDE THERAPEUTICS is 97622958.

What is the registration number for EMPOWERING OLIGONUCLEOTIDE THERAPEUTICS?

EMPOWERING OLIGONUCLEOTIDE THERAPEUTICS is registered under USPTO registration number 7025936.

EMP

USPTO Trademark Record

REGISTERED

EMPOWERING OLIGONUCLEOTIDE THERAPEUTICS

SN 97622958·Reg 7025936·Filed Oct 07, 2022

Owner PepGen Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

EMPOWERING OLIGONUCLEOTIDE THERAPEUTICS (Serial No. 97622958), Registration No. 7025936, is a registered US trademark filed on Oct 07, 2022 by PepGen Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: April 11, 2029

Mark Intelligence

EMPOWERING OLIGONUCLEOTIDE THERAPEUTICS (Reg. #7025936) is a registered US trademark that has been protecting its owner, PepGen Inc., since 2022. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Oct 07, 2022

SERIAL

97622958

REG#

7025936

REGISTERED

Apr 11, 2023

Owner

Applicant

PepGen Inc.

Entity

Corporation

State

Address

245 Main Street, Cambridge, MA, 02142

Country

Attorney

NameJessica L. Rothstein

Law firm

Jessica L. Rothstein GOODWIN PROCTER LLP

Docket

146155327760

Address

620 EIGHTH AVENUE, NEW YORK, NY 10018, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateOct 07, 2022

Serial Number97622958

Registration No.7025936

Registration DateApr 11, 2023

Status DateApr 11, 2023

Published for OppositionJan 24, 2023

Mark TypeStandard characters

Attorney Docket146155327760

Status DescriptionLive and registered

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Mar 31, 2021

First use in commerce: Mar 31, 2021

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

15 events

REGISTERED-PRINCIPAL REGISTER

Apr 11, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 11, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Jan 24, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 24, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 04, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 19, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 16, 2022

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 15, 2022

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 15, 2022

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Dec 02, 2022

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Dec 02, 2022

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 02, 2022

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Dec 01, 2022

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 24, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Oct 11, 2022

NEW APPLICATION ENTERED

EMPOWERING OLIGONUCLEOTIDE THERAPEUTICS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by PepGen Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Jessica L. Rothstein

Resources

Company